Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · Real-Time Price · USD

36.70

+1.04 (2.92%)

At close: Sep 17, 2025, 4:00 PM EDT

36.67

-0.03 (-0.08%)

After-hours: Sep 17, 2025, 6:26 PM EDT

Xenon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	2,830	2,989	3,503	2,466	1,643	554	Upgrade
Market Cap Growth	-18.38%	-14.68%	42.03%	50.06%	196.62%	57.13%	Upgrade
Enterprise Value	2,214	2,195	2,875	1,721	1,397	364	Upgrade
Last Close Price	36.70	39.20	46.06	39.43	31.24	15.38	Upgrade
PS Ratio	377.30	-	-	261.41	89.14	17.22	Upgrade
PB Ratio	4.45	3.96	3.78	3.42	2.99	3.23	Upgrade
P/TBV Ratio	4.46	3.96	3.78	3.42	2.99	3.23	Upgrade
PEG Ratio	-	2.51	2.51	2.51	2.51	2.51	Upgrade
EV/Sales Ratio	295.15	-	-	182.44	75.77	11.31	Upgrade
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02	Upgrade
Asset Turnover	0.01	-	-	0.01	0.05	0.19	Upgrade
Quick Ratio	14.79	17.66	23.43	26.12	38.72	12.10	Upgrade
Current Ratio	15.14	17.85	23.65	26.44	39.03	12.30	Upgrade
Return on Equity (ROE)	-37.65%	-27.85%	-22.12%	-19.72%	-21.87%	-21.90%	Upgrade
Return on Assets (ROA)	-25.52%	-19.80%	-15.57%	-12.17%	-12.97%	-11.61%	Upgrade
Return on Capital (ROIC)	-26.57%	-20.50%	-16.01%	-12.51%	-13.47%	-13.82%	Upgrade
Earnings Yield	-9.83%	-7.84%	-5.21%	-5.08%	-4.80%	-5.21%	Upgrade
FCF Yield	-8.18%	-6.17%	-4.47%	-4.21%	-4.35%	-9.16%	Upgrade
Buyback Yield / Dilution	-7.80%	-16.45%	-10.48%	-38.77%	-21.09%	-23.57%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q